Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.

Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.

Abstract: The invention relates, in part, to compounds, compositions, and methods to reduce infectivity of virus particles and to treat viral infections in subjects.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by elevated threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is elevated as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by elevated TARS activity.

Abstract: Apparatuses, components, methods, and techniques for altering equipment operation are provided. An example tool control and breathable air delivery system includes equipment including a tool and a controller configured to control the tool. The example system also includes a wearable respirator and an air delivery device connected to the wearable respirator. The example system further includes an air evaluation monitor configured to generate a signal based upon a condition of air being delivered to the wearable respirator. An example electronic circuit is configured to adjust the tool based at least in part on the signal generated by the air evaluation monitor. An example method includes enabling the tool, providing air to a respirator, determining a condition of the air, and adjusting the tool based on the condition of the air.

Abstract: Apparatuses, components, methods, and techniques for altering equipment operation are provided. An example tool control and breathable air delivery system includes equipment including a tool and a controller configured to control the tool. The example system also includes a wearable respirator and an air delivery device connected to the wearable respirator. The example system further includes an air evaluation monitor configured to generate a signal based upon a condition of air being delivered to the wearable respirator. An example electronic circuit is configured to adjust the tool based at least in part on the signal generated by the air evaluation monitor. An example method includes enabling the tool, providing air to a respirator, determining a condition of the air, and adjusting the tool based on the condition of the air.

Abstract: Apparatuses, components, methods, and techniques for altering equipment operation are provided. An example tool control and breathable air delivery system includes equipment including a tool and a controller configured to control the tool. The example system also includes a wearable respirator and an air delivery device connected to the wearable respirator. The example system further includes an air evaluation monitor configured to generate a signal based upon a condition of air being delivered to the wearable respirator. An example electronic circuit is configured to adjust the tool based at least in part on the signal generated by the air evaluation monitor. An example method includes enabling the tool, providing air to a respirator, determining a condition of the air, and adjusting the tool based on the condition of the air.

Abstract: The invention relates, in part, to compounds, compositions, and methods to reduce infectivity of virus particles and to treat viral infections in subjects.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by elevated threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is elevated as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by elevated TARS activity.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by reduced threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is reduced as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by reduced TARS activity.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by elevated threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is elevated as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by elevated TARS activity.

Abstract: Apparatuses, components, methods, and techniques for altering equipment operation are provided. An example tool control and breathable air delivery system includes equipment including a tool and a controller configured to control the tool. The example system also includes a wearable respirator and an air delivery device connected to the wearable respirator. The example system further includes an air evaluation monitor configured to generate a signal based upon a condition of air being delivered to the wearable respirator. An example electronic circuit is configured to adjust the tool based at least in part on the signal generated by the air evaluation monitor. An example method includes enabling the tool, providing air to a respirator, determining a condition of the air, and adjusting the tool based on the condition of the air.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by elevated threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is elevated as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by elevated TARS activity.

Abstract: The invention includes, in part, methods and compounds for treating diseases and conditions characterized by reduced threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is reduced as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by reduced TARS activity.